Proteon Therapeutics, Inc. Gains 30.5%
Tue 14 Jan 20 at 05:30 PM
Proteon Therapeutics, Inc. (PRTO:NASDAQ) rocketted at $0.84, a gain of 30.5%. The stock got featured on our News Catalysts scanner on Thu 09 Jan 20 at 07:00 PM in the 'MERGER' category. From Fri 20 Dec 19, the stock recorded 71.43% Up Days and 73.33% Green Days
About Proteon Therapeutics, Inc. (PRTO:NASDAQ)
Proteon Therapeutics Inc is an late-stage biopharmaceutical company engaged in the development of novel pharmaceuticals to address the needs of patients with renal and vascular disease.
Top 10 Gainers:
- RTI Surgical Holdings, Inc. (RTIX:NASDAQ), 63.41%
- Inpixon (INPX:NASDAQ), 54.79%
- IRIDEX Corporation (IRIX:NASDAQ), 48.73%
- Pareteum Corporation (TEUM:NASDAQ), 40.15%
- Pareteum Corporation (TEUM:NYSEMKT), 40.15%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 34.23%
- Big 5 Sporting Goods Corporation (BGFV:NASDAQ), 30.97%
- Ferroglobe PLC (GSM:NASDAQ), 30.87%
- XBiotech Inc. (XBIT:NASDAQ), 30.67%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%